Suppr超能文献

风险管理过程与医疗设备软件生命周期的整合。

The integration of the risk management process with the lifecycle of medical device software.

作者信息

Pecoraro F, Luzi D

机构信息

Fabrizio Pecoraro, National Research Council, Institute for Research on Population and Social Policies, Via Palestro 32, 00185 Rome, Italy, E-mail:

出版信息

Methods Inf Med. 2014;53(2):92-8. doi: 10.3414/ME13-01-0014. Epub 2013 Nov 5.

Abstract

OBJECTIVES

The application of software in the Medical Device (MD) domain has become central to the improvement of diagnoses and treatments. The new European regulations that specifically address software as an important component of MD, require complex procedures to make software compliant with safety requirements, introducing thereby new challenges in the qualification and classification of MD software as well as in the performance of risk management activities. Under this perspective, the aim of this paper is to propose an integrated framework that combines the activities to be carried out by the manufacturer to develop safe software within the development lifecycle based on the regulatory requirements reported in US and European regulations as well as in the relevant standards and guidelines.

METHODS

A comparative analysis was carried out to identify the main issues related to the application of the current new regulations. In addition, standards and guidelines recently released to harmonise procedures for the validation of MD software have been used to define the risk management activities to be carried out by the manufacturer during the software development process.

RESULTS

This paper highlights the main issues related to the qualification and classification of MD software, providing an analysis of the different regulations applied in Europe and the US. A model that integrates the risk management process within the software development lifecycle has been proposed too. It is based on regulatory requirements and considers software risk analysis as a central input to be managed by the manufacturer already at the initial stages of the software design, in order to prevent MD failures.

CONCLUSIONS

Relevant changes in the process of MD development have been introduced with the recognition of software being an important component of MDs as stated in regulations and standards. This implies the performance of highly iterative processes that have to integrate the risk management in the framework of software development. It also makes it necessary to involve both medical and software engineering competences to safeguard patient and user safety.

摘要

目标

软件在医疗设备(MD)领域的应用已成为改善诊断和治疗的核心。新的欧洲法规特别将软件视为MD的重要组成部分,要求采用复杂程序使软件符合安全要求,从而在MD软件的鉴定和分类以及风险管理活动的开展方面带来了新挑战。从这一角度来看,本文旨在提出一个综合框架,该框架结合了制造商在开发生命周期内基于美国和欧洲法规以及相关标准和指南中报告的监管要求来开发安全软件所需开展的活动。

方法

进行了一项比较分析,以确定与当前新法规应用相关的主要问题。此外,最近发布的用于协调MD软件验证程序的标准和指南已被用于定义制造商在软件开发过程中要开展的风险管理活动。

结果

本文突出了与MD软件鉴定和分类相关的主要问题,对欧洲和美国适用的不同法规进行了分析。还提出了一个将风险管理过程整合到软件开发生命周期内的模型。它基于监管要求,并将软件风险分析视为制造商在软件设计初始阶段就需管理的核心输入,以防止MD故障。

结论

随着法规和标准中规定软件是MD的重要组成部分,MD开发过程已引入了相关变化。这意味着要执行高度迭代的过程,这些过程必须将风险管理整合到软件开发框架中。这也使得有必要让医学和软件工程能力都参与进来,以保障患者和用户安全。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验